Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,380 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Serum Inflamma-miR Signature: A Biomarker of Myelodysplastic Syndrome?
Mariani M, Mattiucci D, Rossi E, Mari V, Masala E, Giuliani A, Santini V, Olivieri F, Marinelli Busilacchi E, Mancini S, Olivieri A, Poloni A. Mariani M, et al. Front Oncol. 2020 Nov 20;10:595838. doi: 10.3389/fonc.2020.595838. eCollection 2020. Front Oncol. 2020. PMID: 33330086 Free PMC article. No abstract available.
The exosomal surface phenotype and inflamma-miR cargo correlate with MDS diagnosis.
Cerisoli S, Marinelli Busilacchi E, Mattiucci D, Rossi E, Mariani M, Guescini M, Pugnaloni A, Olivieri F, Olivieri A, Poloni A. Cerisoli S, et al. Among authors: mariani m. Br J Haematol. 2021 Jan;192(1):e4-e7. doi: 10.1111/bjh.17113. Epub 2020 Oct 23. Br J Haematol. 2021. PMID: 33095921 Free article. No abstract available.
Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromes.
Poloni A, Goteri G, Zizzi A, Serrani F, Trappolini S, Costantini B, Mariani M, Olivieri A, Catarini M, Centurioni R, Alesiani F, Giantomassi F, Stramazzotti D, Biagetti S, Alfonsi S, Berardinelli E, Leoni P. Poloni A, et al. Among authors: mariani m. Eur J Haematol. 2013 Sep;91(3):219-227. doi: 10.1111/ejh.12145. Epub 2013 Jun 28. Eur J Haematol. 2013. PMID: 23679560
Severe COVID-19 in a patient with chronic graft-versus-host disease after hematopoietic stem cell transplant successfully treated with ruxolitinib.
Saraceni F, Scortechini I, Mancini G, Mariani M, Federici I, Gaetani M, Barbatelli P, Minnucci ML, Bagnarelli P, Olivieri A. Saraceni F, et al. Among authors: mariani m. Transpl Infect Dis. 2021 Feb;23(1):e13401. doi: 10.1111/tid.13401. Epub 2020 Jul 14. Transpl Infect Dis. 2021. PMID: 32629531 Free PMC article.
1,380 results